Patents by Inventor Barbara Denise Fazekas De St Groth

Barbara Denise Fazekas De St Groth has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9291623
    Abstract: The present invention relates to methods and kits for identifying, quantifying and isolating regulatory T cells, to methods and kits for diagnosing or monitoring autoimmune diseases, immunoinflammatory diseases, allergic diseases, predispositions thereto, infectious diseases, cancer, cancer treatment and/or organ transplantation based on regulatory T cell quantity, to methods and kits for predicting responses to therapy for autoimmune diseases, immunoinflammatory diseases, allergic diseases, predispositions thereto, infectious diseases, cancer and/or organ transplantation based on regulatory T cell quantity, and to methods and kits for therapy using isolated regulatory T cells.
    Type: Grant
    Filed: April 15, 2011
    Date of Patent: March 22, 2016
    Assignee: CENTENARY INSTITUTE OF CANCER MEDICINE AND CELL BIOLOGY
    Inventors: Barbara Denise Fazekas De St Groth, Anthony Dominic Kelleher, Alan Lee Landay, Sarah Christina Sasson, Nabila Seddiki, John James Zaunders
  • Publication number: 20110318749
    Abstract: The present invention relates to methods and kits for identifying, quantifying and isolating regulatory T cells, to methods and kits for diagnosing or monitoring autoimmune diseases, immunoinflammatory diseases, allergic diseases, predispositions thereto, infectious diseases, cancer, cancer treatment and/or organ transplantation based on regulatory T cell quantity, to methods and kits for predicting responses to therapy for autoimmune diseases, immunoinflammatory diseases, allergic diseases, predispositions thereto, infectious diseases, cancer and/or organ transplantation based on regulatory T cell quantity, and to methods and kits for therapy using isolated regulatory T cells.
    Type: Application
    Filed: April 15, 2011
    Publication date: December 29, 2011
    Applicant: CENTENARY INSTITUTE OF CANCER MEDICINE AND CELL BIOLOGY
    Inventors: Barbara Denise FAZEKAS DE ST GROTH, Anthony Dominic Kelleher, Alan Lee Landay, Sarah Christina Sasson, Nabila Seddiki, John James Zaunders
  • Patent number: 7947464
    Abstract: The present invention relates to methods and kits for identifying, quantifying and isolating regulatory T cells, to methods and kits for diagnosing or monitoring autoimmune diseases, immunoinflammatory diseases, allergic diseases, predispositions thereto, infectious diseases, cancer, cancer treatment and/or organ transplantation based on regulatory T cell quantity, to methods and kits for predicting responses to therapy for autoimmune diseases, immunoinflammatory diseases, allergic diseases, predispositions thereto, infectious diseases, cancer and/or organ transplantation based on regulatory T cell quantity, and to methods and kits for therapy using isolated regulatory T cells.
    Type: Grant
    Filed: July 31, 2006
    Date of Patent: May 24, 2011
    Assignee: Centenary Institute of Cancer Medicine and Cell Biology
    Inventors: Barbara Denise Fazekas De St Groth, Anthony Dominic Kelleher, Alan Lee Landay, Sarah Christina Sasson, Nabila Seddiki, John James Zaunders
  • Publication number: 20100028865
    Abstract: The present invention relates to methods and kits for identifying, quantifying and isolating regulatory T cells, to methods and kits for diagnosing or monitoring autoimmune diseases, immunoinflammatory diseases, allergic diseases, predispositions thereto, infectious diseases, cancer, cancer treatment and/or organ transplantation based on regulatory T cell quantity, to methods and kits for predicting responses to therapy for autoimmune diseases, immunoinflammatory diseases, allergic diseases, predispositions thereto, infectious diseases, cancer and/or organ transplantation based on regulatory T cell quantity, and to methods and kits for therapy using isolated regulatory T cells.
    Type: Application
    Filed: July 31, 2006
    Publication date: February 4, 2010
    Inventors: Barbara Denise Fazekas De St Groth, Anthony Dominic Kelleher, Alan Lee Landay, Sarah Christina Sasson, Nabila Seddiki, John James Zaunders